Author(s): Sanatkumar Bharamu Nyamagoud, Agadi Hiremath Viswanatha Swamy, Bharati Kangrali

Email(s): vmhiremath2004@gmail.com

DOI: 10.52711/0974-360X.2024.00389   

Address: Sanatkumar Bharamu Nyamagoud1, Agadi Hiremath Viswanatha Swamy1*, Bharati Kangrali2
1Department of Pharmacy Practice, KLE College of Pharmacy, Vidyanagar, Hubballi. A Constituent Unit of KLE Academy of Higher Education and Research, Belagavi, Karnataka, India.
2Department of General Medicine, Vivekanand General Hospital, Deshpande Nagar, Hubballi.
*Corresponding Author

Published In:   Volume - 17,      Issue - 6,     Year - 2024


ABSTRACT:
Background: Diabetes mellitus is a chronic metabolic condition defined by elevated blood glucose levels caused by abnormalities in insulin secretion, insulin action, or both. Anti-diabetic drug pharmacovigilance can be extremely useful in identifying and resolving the adverse drug reactions (ADRs) and safeguarding patients from needless injury. Objective: The objective of the study was to determine the prevalence of various adverse events caused by the use of anti-diabetic medications in patients treated at tertiary care hospital. Method: It was a randomized controlled study where the participants were randomized into two groups i.e., interventional or study group and control group. All suspected ADRs were collected, analysed and confirmed by the physician-in-charge and were assessed for causality using WHO-UMC Causality Categories, Naranjo’s causality assessment scale, preventability using Modified-Schumock and Thornton scale, severity using Modified Hartwig and Siegel scale by the Causality Assessment Committee (CAC). Results: The study included a total of 300 subjects among which 218 were male (72.67%) and 82 were female (27.33%). A total of 300 patients, 104 ADRs were identified, in which 46.15% were observed in the control group and 53.85% in the interventional group. Females were more prevalent to the ADRs. The majority of ADRs were seen in age group of >70 in which 15.38% were observed in the control group and 18.27% in the interventional group. The Highest observed ADR of 20 (19.23%) was Hypoglycemia in which 9(8.65) were observed in the control group and 11(10.57) in the interventional group followed by weight gain i.e, 10 (9.61%) in which 5(4.80%) were observed in the control group and 5(4.80%) in the interventional group. Conclusion: ADR relating to antidiabetic therapy utilizing oral antidiabetics and insulin was found to be prevalent. The doctors and clinical pharmacists are therefore needed to identify and report the appropriate signals generated to the nearest ADR monitoring centre or Pharmacovigilance Programme of India for the benefit of the patients.


Cite this article:
Sanatkumar Bharamu Nyamagoud, Agadi Hiremath Viswanatha Swamy, Bharati Kangrali. Prevalence of Adverse Drug Reactions in Diabetic patients receiving Antidiabetic Medications at Tertiary Care Hospital. Research Journal of Pharmacy and Technology. 2024; 17(6):2486-2. doi: 10.52711/0974-360X.2024.00389

Cite(Electronic):
Sanatkumar Bharamu Nyamagoud, Agadi Hiremath Viswanatha Swamy, Bharati Kangrali. Prevalence of Adverse Drug Reactions in Diabetic patients receiving Antidiabetic Medications at Tertiary Care Hospital. Research Journal of Pharmacy and Technology. 2024; 17(6):2486-2. doi: 10.52711/0974-360X.2024.00389   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-6-8


REFERENCE:
1.    Hameed S, Kumar P, Kumar M, Mohan L, Dikshit H. Evaluation of suspected adverse drug reactions of oral anti-diabetic drugs in a tertiary care hospital of Bihar, India: An observational study. Panacea Journal of Medical Sciences. 2022 Apr 15;12(1): 172–176. doi: 10.18231/J.PJMS.2022.032.
2.    Singh A, Dwivedi S. Study of adverse drug reactions in patients with diabetes attending a tertiary care hospital in New Delhi, India. Indian Journal of Medical Research. 2017 Feb 1;145: 247–249. doi: 10.4103/ijmr.IJMR_109_16.
3.    Deb T, Chakrabarty A, Ghosh A. Adverse drug reactions in Type 2 diabetes mellitus patients on oral antidiabetic drugs in a diabetes outpatient department of a tertiary care teaching hospital in the Eastern India. International Journal of Medical Science and Public Health. 2017;6(3): 1. doi: 10.5455/ijmsph.2017.0423203102016.
4.    Muthukumar A, SundaraGanapathy R, Suganthi S, Ramu T, Mohan S. A pharmacovigilance study on drugs used in the treatment and management of hypertension in tirupur zone. International Journal of Recent Scientific Research. 2017 May 28;08(05): 17196–17199. doi: 10.24327/IJRSR.2017.0805.0302.
5.    Shaik RA, Jaffer S, Fatima SH. Study on prevalence of adverse drug reactions and drug-drug interactions and co-morbid conditions of patients suffering from tuberculosis. Research Journal of Pharmacy and Technology. 2021 July 19;14(7): 3911–3915. doi: 10.52711/0974-360X.2021.00679.
6.    Adade CA, Cheikh A, Mefetah H, Kili A, Hessissen L, Bouatia M. Adverse effects of Anticancer Chemotherapy in Childhood Cancer: A Prospective Study in a Moroccan hospital. Research Journal of Pharmacy and Technology. 2022 Jun 28;15(6): 2559–2564. doi: 10.52711/0974-360X.2022.00428.
7.    Inasu ST, Kumudavalli M V., Venkateswarlu BS. Clinical Pharmacist role and their Importance in the Systematic Analysis of Diabetes Management Studies. Research Journal of Pharmacy and Technology. 2022 Nov 24;15(11): 5273–5277. doi: 10.52711/0974-360X.2022.00888.
8.    Boopathi D, Akshatha JS, Buggi U, Siva H, Arun KP, Mani D. Analysis of Adverse Drug Reactions associated with Anti-tubercular drugs – A Retrospective Study. Research Journal of Pharmacy and Technology. 2022 Apr 23;15(4): 1483–1486. doi: 10.52711/0974-360X.2022.00246.
9.    Rani N, Deb T, Beniwal A, Singh A. ADR profile among healthcare workers on Hydroxychloroquine prophylaxis in a tertiary care teaching hospital in India. Research Journal of Pharmacy and Technology. 2022 Nov 24;15(11): 5202–5205. doi: 10.52711/0974-360X.2022.00876.
10.    Elangwe A, Katte JC, Tchapmi D, Figueras A, Mbanya JC. Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in sub-Saharan Africa. European Journal of Clinical Pharmacology. 2020 Nov 1; 76(11): 1601–1605. doi: 10.1007/s00228-020-02949-2.
11.    Khairnar A, Gade PR. Interventional improvement in hospital based intensive monitoring of adverse event. Research Journal of Pharmacy and Technology. 2011; 4(9): 1443–1448. www.rjptonline.org
12.    Das P, Nayak J, Swain SP. Adverse Drug Reaction Monitoring of Antidepressant Drugs in a Mental Health Institute in Odisha. Research Journal of Pharmacy and Technology. 2021 Dec 28; 14(12): 6479–6483. doi: 10.52711/0974-360X.2021.01120.
13.    Birhane H, Islam M, H/mariam D, Singh V. Pharmacovigilance: adverse drug reactions (Adrs) in pediatric patients in ethiopia. retrospective study. Research Journal of Pharmacy and Technology. 2021 Mar 18; 14(3): 1499–1506. doi: 10.5958/0974-360X.2021.00266.3.
14.    Divya A, Shetageri VN, Mathew VK. Drug utilization evaluation of olanzapine and assessment of adverse drug reactions associated in psychotic patients in a tertiary care hospital. Research Journal of Pharmacy and Technology. 2021 Mar 18; 14(3): 1395–1399. doi: 10.5958/0974-360X.2021.00249.3.
15.    Kumar S, Badruddeen, Singh SP, Akhtar J, Khan MI, Ahmad M, et al. Assessment of analgesics induced adverse drug reactions in a tertiary care Hospital. Research Journal of Pharmacy and Technology. 2020 Oct 12; 13(10): 4861. doi: 10.5958/0974-360x.2020.00855.0.
16.    Comfort S, Dorrell D, Meireis S, Fine J. MOdified NARanjo Causality Scale for ICSRs (MONARCSi): A Decision Support Tool for Safety Scientists. Drug Safety. 2018 Nov 1; 41(11): 1073–1085. doi: 10.1007/s40264-018-0690-y.
17.    Parida S. Clinical causality assessment for adverse drug reactions. Indian Journal of Anaesthesia. 2013 May; 57(3): 325–326. doi: 10.4103/0019-5049.115608.
18.    Badar V, Parulekar VV, Garate P. A surveillance study of cutaneous adverse drug reactions in a tertiary care teaching hospital in India. International Journal of Basic & Clinical Pharmacology. 2018 Nov 24; 7(12): 2439. doi: 10.18203/2319-2003.ijbcp20184862.
19.    Saqib A, Sarwar MR, Sarfraz M, Iftikhar S. Causality and preventability assessment of adverse drug events of antibiotics among inpatients having different lengths of hospital stay: A multicenter, cross-sectional study in Lahore, Pakistan. BMC Pharmacology and Toxicology. 2018 Jun 25; 19(1). doi: 10.1186/s40360-018-0222-5.
20.    Mishra S, Nigam N, Ahmad SS, Shankar P, Kumar S, Kumar V, et al. Adverse drug reaction monitoring amongst diabetic patients of tertiary care centre of northern india related to anti-diabetic drugs. International Journal of Pharmaceutical Sciences and Research. 2021 Mar 1; 12(3): 1915–1922. doi: 10.13040/IJPSR.0975-8232.12(3).1915-22.
21.    Singh S, Singh PP, Singh AG, Murad MH, Sanchez W. Anti-diabetic medications and the risk of hepatocellular cancer: A systematic review and meta-analysis. American Journal of Gastroenterology. 2013 Jun; 108(6): 881–891. doi: 10.1038/ajg.2013.5.
22.    Saravanan K, Manna P, Mohanta G, Manavalan R. A study of adverse drug reaction on drugs used in the management of type 2 diabetic mellitus. Journal of Pharmacy Research. 2011; 4(10): 3394–3395. https://journals.indexcopernicus.com/search/article?articleId=898092
23.    Nessa A, Rahman SA, Hussain K. Hyperinsulinemic hypoglycemia- the molecular mechanisms. Frontiers in Endocrinology. 2016 Mar 31;7. doi: 10.3389/fendo.2016.00029.
24.    Garg A. Lipodystrophies: Genetic and acquired body fat disorders. Journal of Clinical Endocrinology and Metabolism. 2011 Nov 1; 96(11): 3313–3325. doi: 10.1210/jc.2011-1159.
25.    Kadiyala P, Walton S, Sathyapalan T. Insulin induced lipodystrophy. British Journal of Diabetes and Vascular Disease. 2014 Nov 24; 14(4): 131–133. doi: 10.15277/bjdvd.2014.036.
26.    Anovadiya AP, Barvaliya MJ, Shah RA, Ghori VM, Sanmukhani JJ, Patel TK, et al. Adverse drug reaction profile of oseltamivir in Indian population: A prospective observational study. Indian Journal of Pharmacology. June 2011; 43(3): 258–261. doi: 10.4103/0253-7613.81509.
27.    Shareef J, Fernandes J, Samaga L. Assessment of clinical pharmacist interventions in drug therapy in patients with diabetes mellitus in a tertiary care teaching hospital. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2016 Apr 1; 10(2): 82–87. doi: 10.1016/j.dsx.2015.09.017.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available